Concepedia

Douglas H. Yamada

DH

Statistics

Publications

9

Citations

1.7K

H-Index

9

Active since

2009

Affiliations

University of California, Los Angeles(Current)

Black AIDS Institute

Princess Margaret Cancer Centre

University of Toronto

University Health Network

Douglas H. Yamada is an author at University of California, Los Angeles specializing in medicine, immunology, and viral immunity.

Top concepts

Publications per year

2009–2018

9

Publications

9

Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

Elizabeth Wilson, Douglas H. Yamada, Heidi Elsaesser et al. · Science · 2013 · 696 citations · Full text

, , +23

Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling

Autumn G. York, Kevin J. Williams, Joseph P. Argus et al. · Cell · 2015 · 435 citations · Full text

, , +9

Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity

Karla R. Wiehagen, Natasha Girgis, Douglas H. Yamada et al. · Cancer Immunology Research · 2017 · 159 citations · Full text

Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection

Ivan Osokine, Laura M. Snell, Cameron R. Cunningham et al. · Proceedings of the National Academy of Sciences · 2014 · 101 citations · Full text

Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection

Laura M. Snell, Ivan Osokine, Douglas H. Yamada et al. · Cell Reports · 2016 · 97 citations · Full text

, , +15

Rows per page

1–5 of 9